Sven Wind
Impact in
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 14
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 4
-
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Harald Schmidt (2 shared papers)Rudi Busse (1 shared paper)Ralf P. Brandes (1 shared paper)Eduardo Barbosa‐Sicard (1 shared paper)Katrin Schröder (1 shared paper)Peter Stopfer (8 shared papers)Matthias Freiwald (3 shared papers)Thomas Ebner (2 shared papers)
- Journals
- Annals of Oncology (4 papers)Journal of Clinical Oncology (3 papers)Clinical Pharmacokinetics (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Cancer Research (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Sven Wind
39 papers receiving 2.2k citations
Sven Wind's Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology 435
- Oncology 501
- Physiology 473
- Pulmonary and Respiratory Medicine 537
- Genetics 160
Countries citing papers authored by Sven Wind
This map shows the geographic impact of Sven Wind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Wind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Wind more than expected).
Fields of papers citing papers by Sven Wind
This network shows the impact of papers produced by Sven Wind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Wind. The network helps show where Sven Wind may publish in the future.
Co-authors
The 25 scholars most cited alongside Sven Wind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant Hit paper breakdown → | 2007 | 653 |
| 2 | 2010 | 216 | |
| 3 | 2012 | 167 | |
| 4 | 2016 | 154 | |
| 5 | 2010 | 152 | |
| 6 | 2019 | 147 | |
| 7 | 2014 | 141 | |
| 8 | 2013 | 78 | |
| 9 | 2012 | 73 | |
| 10 | 2012 | 66 | |
| 11 | 2014 | 55 | |
| 12 | 2014 | 42 | |
| 13 | 2018 | 34 | |
| 14 | 2014 | 33 | |
| 15 | 2013 | 32 | |
| 16 | 2017 | 30 | |
| 17 | 2018 | 27 | |
| 18 | 2018 | 22 | |
| 19 | 2016 | 17 | |
| 20 | 2011 | 12 |
About Sven Wind
Sven Wind is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Molecular Biology and Genetics, having authored 39 papers that have together received 2.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Lung Cancer Treatments and Mutations (9 papers), Cancer Treatment and Pharmacology (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Amino Acid Enzymes and Metabolism (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Immunology (435 citations), Oncology (501 citations), Physiology (473 citations), Pulmonary and Respiratory Medicine (537 citations) and Genetics (160 citations). Sven Wind has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Harald Schmidt, Rudi Busse, Ralf P. Brandes, Eduardo Barbosa‐Sicard, Katrin Schröder, Peter Stopfer, Matthias Freiwald, Thomas Ebner, Kirstin Wingler and Knut Beuerlein. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Clinical Pharmacokinetics, Cancer Chemotherapy and Pharmacology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.